# Interest of Gentamicin-induced Readthrough in Cystic Fibrosis Patients

> **NCT00376428** · PHASE2 · TERMINATED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 20 (—)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DRUG:** Gentamicin

## Key facts

- **NCT ID:** NCT00376428
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2003-01
- **Primary completion:** —
- **Final completion:** 2005-06
- **Target enrollment:** 20 (—)
- **Last updated:** 2015-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00376428

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00376428, "Interest of Gentamicin-induced Readthrough in Cystic Fibrosis Patients". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00376428. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*